Last updated 45 days ago

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

668 patients around the world
Available in Mexico, United States, Brazil
OBI Pharma, Inc
5Research sites
668Patients around the world
This study is for people with
Breast Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul
Recruiting
Av. Ipiranga, 6690 - 4º andar - Partenon, Porto Alegre - RS, 90610-001, Brazil
Catatina Pesquisa Clinica - Clinica de Neoplasias Litoral
Recruiting
Itajai, 88331-10
Hospital Amaral Carvalho
Recruiting
R. Doná Silvéria, 150 - Chácara Braz Miraglia, Jaú - SP, 17210-080, Brazil
Clínica de Pesquisas e Centro de Estudos em Oncologia Ginecológica e Mamária
Recruiting
733 Avenida Brigadeiro Luís Antônio São Paulo, SP 01317-001
Icaro Investigaciones en Medicina S.A. de C.V.
Recruiting
Chihuahua, 31000
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy